ask="2.96"
ask_size="200"
average_daily_volume="236153"
bid="1.80"
bid_size="500"
book_value="3.15"
change="-0.06"
change_from_200_day_moving_average="-0.60"
change_from_50_day_moving_average="-0.40"
change_from_52_week_high="-6.38"
change_From_52_week_low="0.22"
change_in_percent="-3.05%"
close="1.91"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.70"
ebitda="-56.49M"
eps_estimate_current_year="-5.24"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-2.96"
ex_dividend_date="N/A"
float_shares="14677000"
high="1.94"
high_52_weeks="8.29"
last_trade_date="2/8/2017"
last_trade_price="1.91"
last_trade_size="4125"
last_trade_time="4:00pm"
low="1.85"
low_52_weeks="1.69"
market_capitalization="38.67M"
moving_average_200_day="2.51"
moving_average_50_day="2.31"
name="Aptevo Therapeutics Inc."
notes="N/A"
one_year_target_price="5.00"
open="1.93"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-23.95%"
percent_change_from_50_day_moving_average="-17.34%"
percent_change_from_52_week_high="-76.96%"
percent_change_from_52_week_low="+13.02%"
previous_close="1.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.63"
price_per_sales="1.11"
revenue="35.95M"
shares_outstanding="20248000"
short_ratio="1.98"
stock_exchange="NMS"
symbol="APVO"
volume="168664"
weeks_range_52="1.69 - 8.29"
